Cardiac Sarcoidosis

被引：30

作者：

Birnie, David ^{[1
]}

Ha, Andrew C. T. ^{[2
]}

Gula, Lorne J. ^{[3
]}

Chakrabarti, Santabhanu ^{[4
]}

Beanlands, Rob S. B. ^{[1
]}

Nery, Pablo ^{[1
]}

机构：

[1] Univ Ottawa, Inst Heart, Div Cardiol, Ottawa, ON K1Y 4W7, Canada

[2] Univ Toronto, Univ Hlth Network, Peter Munk Cardiac Ctr, Dept Med, Toronto, ON M5G 2C4, Canada

[3] London Hlth Sci Ctr, Div Cardiol, London, ON N6A 5A5, Canada

[4] Univ British Columbia, Dept Med, Div Cardiol, Vancouver, BC V6E 1M7, Canada

来源：

CLINICS IN CHEST MEDICINE | 2015年 / 36卷 / 04期

关键词：

Cardiac sarcoidosis; Clinically silent; Clinically manifest; Atrioventricular block; Ventricular arrhythmias; Heart failure; Sudden cardiac death; POSITRON-EMISSION-TOMOGRAPHY; COLLEGE-OF-CARDIOLOGY; VENTRICULAR-TACHYCARDIA; ENDOMYOCARDIAL BIOPSY; CORTICOSTEROID-THERAPY; ATRIOVENTRICULAR-BLOCK; MYOCARDIAL INVOLVEMENT; CONSENSUS STATEMENT; HEART-ASSOCIATION; STEROID-THERAPY;

D O I：

10.1016/j.ccm.2015.08.008

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Studies suggest clinically manifest cardiac involvement occurs in 5% of patients with pulmonary/systemic sarcoidosis. The principal manifestations of cardiac sarcoidosis (CS) are conduction abnormalities, ventricular arrhythmias, and heart failure. Data indicate that a 20% to 25% of patients with pulmonary/systemic sarcoidosis have asymptomatic (clinically silent) cardiac involvement. An international guideline for the diagnosis and management of CS recommends that patients be screened for cardiac involvement. Most studies suggest a benign prognosis for patients with clinically silent CS. Immunosuppression therapy is advocated for clinically manifest CS. Device therapy, with implantable cardioverter defibrillators, is recommended for some patients.

引用

页码：657 / +

页数：13

共 75 条

[31] Cardiac sarcoidosis [J].

Kim, Jessica S. ;

Judson, Marc A. ;

Donnino, Robert ;

Gold, Michael ;

Cooper, Leslie T., Jr. ;

Prystowsky, Eric N. ;

Prystowsky, Stephen .

AMERICAN HEART JOURNAL, 2009, 157 (01) :9-21

[32] Refractory ventricular tachycardia secondary to cardiac sarcoid: Electrophysiologic characteristics, mapping, and ablation [J].

Koplan, Bruce A. ;

Soejima, Kyoko ;

Baughman, Kenneth ;

Epstein, Laurence M. ;

Stevenson, William G. .

HEART RHYTHM, 2006, 3 (08) :924-929

[33] Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis [J].

Kron, Jordana ;

Sauer, William ;

Schuller, Joseph ;

Bogun, Frank ;

Crawford, Thomas ;

Sarsam, Sinan ;

Rosenfeld, Lynda ;

Mitiku, Teferi Y. ;

Cooper, Joshua M. ;

Mehta, Davendra ;

Greenspon, Arnold J. ;

Ortman, Matthew ;

Delurgio, David B. ;

Valadri, Ravinder ;

Narasimhan, Calambur ;

Swapna, Nalla ;

Singh, Jagmeet P. ;

Danik, Stephan ;

Markowitz, Steven M. ;

Almquist, Adrian K. ;

Krahn, Andrew D. ;

Wolfe, Luke G. ;

Feinstein, Shawn ;

Ellenbogen, Kenneth A. .

EUROPACE, 2013, 15 (03) :347-354

[34] Myocardial washout of 99mTc-tetrofosmin and response to steroid therapy in patients with cardiac sarcoidosis [J].

Kudoh, Hirokazu ;

Fujiwara, Sei ;

Shiotani, Hideyuki ;

Kawai, Hiroya ;

Hirata, Kenichi .

ANNALS OF NUCLEAR MEDICINE, 2010, 24 (05) :379-385

[35] Effectiveness of prolonged fasting 18f-FDG PET-CT in the detection of cardiac sarcoidosis [J].

Langah, Rumman ;

Spicer, Kenneth ;

Gebregziabher, Mulugeta ;

Gordon, Leonie .

JOURNAL OF NUCLEAR CARDIOLOGY, 2009, 16 (05) :801-810

[36] 2011 Consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology [J].

Leone, Ornella ;

Veinot, John P. ;

Angelini, Annalisa ;

Baandrup, Ulrik T. ;

Basso, Cristina ;

Berry, Gerald ;

Bmneval, Patrick ;

Burke, Margaret ;

Butany, Jagdish ;

Calabrese, Fiorella ;

d'Amati, Giulia ;

Edwards, William D. ;

Fallon, John T. ;

Fishbein, Michael C. ;

Gallagher, Patrick J. ;

Halushka, Marc K. ;

McManus, Bruce ;

Pucci, Angela ;

Rodriguez, E. Rene ;

Saffitz, Jeffrey E. ;

Sheppard, Mary N. ;

Steenbergen, Charles ;

Stone, James R. ;

Tan, Carmela ;

Thiene, Gaetano ;

van der Wal, Allard C. ;

Winters, Gayle L. .

CARDIOVASCULAR PATHOLOGY, 2012, 21 (04) :245-274

[37] Cardiac sarcoidosis: Recurrent disease in a heart transplant patient following pulmonary tuberculosis infection [J].

Luk, Adriana ;

Lee, Andrew ;

Ahn, Eric ;

Soor, Gursharan S. ;

Ross, Heather J. ;

Butany, Jagdish .

CANADIAN JOURNAL OF CARDIOLOGY, 2010, 26 (07) :E273-E275

[38] CLINICOPATHOLOGICAL STUDY ON FATAL MYOCARDIAL SARCOIDOSIS [J].

MATSUI, Y ;

IWAI, K ;

TACHIBANA, T ;

FRUIE, T ;

SHIGEMATSU, N ;

IZUMI, T ;

HOMMA, AH ;

MIKAMI, R ;

HONGO, O ;

HIRAGA, Y ;

YAMAMOTO, M .

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1976, 278 (SEP9) :455-469

[39] The role of F18-fluorodeoxyglucose positron emission tomography in guiding diagnosis and management in patients with known or suspected cardiac sarcoidosis [J].

Mc Ardle, B. A. ;

Leung, E. ;

Ohira, H. ;

Cocker, M. S. ;

deKemp, R. A. ;

DaSilva, J. ;

Birnie, D. ;

Beanlands, R. S. ;

Nery, P. B. .

JOURNAL OF NUCLEAR CARDIOLOGY, 2013, 20 (02) :297-306

[40] Is There an Association Between Clinical Presentation and the Location and Extent of Myocardial Involvement of Cardiac Sarcoidosis as Assessed by 18F-Fluorodoexyglucose Positron Emission Tomography? [J].

Mc Ardle, Brian A. ;

Birnie, David H. ;

Klein, Ran ;

de Kemp, Rob A. ;

Leung, Eugene ;

Renaud, Jennifer ;

DaSilva, Jean ;

Wells, George A. ;

Beanlands, Rob S. ;

Nery, Pablo B. .

CIRCULATION-CARDIOVASCULAR IMAGING, 2013, 6 (05) :617-626

← 1 2 3 4 5 6 7 8 →